Migraine Support
Natural health product licensed in Canada
- Other names
- MigraSol, Migraine Pro
- Licence holder
- Vitazan Herbs and Vitamins Inc
- NPN or DIN-HM
- 80121327
- Status
- Active licence
- Licence date
- 27 September 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 371.56 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 371.56 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Méthylcobalamine | 125 Microgrammes | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Whole | 37.5 mg | Not calculated |
| Magnésium Source : Bisglycinate de magnésium | 92.89 mg | 371,560 µg |
| Riboflavine Source : Riboflavine 5'-phosphate | 12.5 mg | 50,000 µg |
| Riboflavine Source : Riboflavine | 37.5 mg | 150,000 µg |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 92 Microgrammes | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Dioxyde de silicium, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 4 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism, tissue formation and bone development. Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps in the normal function of the immune system. Helps to form red blood cells. Helps to maintain healthy metabolism. Helps to maintain healthy mucous membranes. Helps to maintain normal electrolyte balance. Helps to maintain normal metabolism of iron. Helps to maintain normal red blood cells. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent riboflavin deficiency. Helps to prevent vitamin B12 deficiency. Maintains good health. Provides/Source of/An electrolyte (for the maintenance of good health). Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Vitamin and mineral supplement. (Provides) An antioxidant. Helps to maintain and/or support cardiovascular health. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic/preventative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80121327
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.